Xiao Ying Meng
Directeur/Membre du Conseil chez BMC MEDICAL CO., LTD.
Profil
Xiao Ying Meng is currently the Director at BMC Medical Co. Ltd.
since 2019 and the Non-Executive Director at TYK Medicines, Inc. since 2021.
Previously, she worked as a Member-Supervisory Board at Chengdu Bright Eye Hospital Co., Ltd.
from 2018 to 2022.
Dr. Meng holds a doctorate degree from The Pennsylvania State University, an undergraduate degree from Nanjing University, and a graduate degree from Nanjing University.
Postes actifs de Xiao Ying Meng
| Sociétés | Poste | Début |
|---|---|---|
| BMC MEDICAL CO., LTD. | Directeur/Membre du Conseil | 01/12/2019 |
TYK Medicines, Inc.
 TYK Medicines, Inc. Pharmaceuticals: MajorHealth Technology TYK Medicines, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the business of research, development and commercialization of pharmaceutical products and differentiated targeted therapies to address unmet medical needs in cancer treatment. The company was founded by Wu Yusheng on November 2, 2017 and is headquartered in Huzhou, China. | Directeur/Membre du Conseil | 01/01/2021 |
Anciens postes connus de Xiao Ying Meng
| Sociétés | Poste | Fin |
|---|---|---|
| CHENGDU BRIGHT EYE HOSPITAL CO., LTD. | Directeur/Membre du Conseil | 10/10/2022 |
Formation de Xiao Ying Meng
| Nanjing University | Undergraduate Degree |
| The Pennsylvania State University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CHENGDU BRIGHT EYE HOSPITAL CO., LTD. | Health Services |
| BMC MEDICAL CO., LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
TYK Medicines, Inc.
TYK Medicines, Inc. Pharmaceuticals: MajorHealth Technology TYK Medicines, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the business of research, development and commercialization of pharmaceutical products and differentiated targeted therapies to address unmet medical needs in cancer treatment. The company was founded by Wu Yusheng on November 2, 2017 and is headquartered in Huzhou, China. | Health Technology |
